News

In the trial, Phenserine, which is in development for mild to moderate Alzheimer’s disease (AD), failed to result in a statistically significant improvement over placebo for the protocol’s

The national antiviral stockpile will be used to treat identified priority groups, agreed upon by a national expert advisory committee on pandemic influenza. The federal contribution goes towards

The researchers stated that, because oral therapy can be started more quickly and is less painful than intravenous (IV) treatment, it should be the preferred treatment for children

The varicella vaccine is almost 90% effective against chickenpox but its impact on herpes zoster (shingles) is unknown and needs wider surveillance, according to the researchers. The varicella

Reports so far suggest that the FDA believes the cardiovascular risks that resulted in Merck’s voluntary withdrawal of Vioxx (rofecoxib) are a class effect. As well as looking

The suit challenges the FDA’s policy of awarding generic exclusivity on a patent-by-patent basis. Barr believes that this policy is contrary to the Hatch-Waxman Act, and that it

Viragen is seeking to have the approval include the first-line adjuvant treatment of high-risk malignant melanoma following dacarbazine (DTIC) after surgical removal of tumors. This submission represents the

Novavax’ virus like particle (VLP) technology uses recombinant protein technology to imitate the structure of a virus to provide protection without the risk of infection or disease. Unlike

The preclinical study evaluated the local administration of Combretastatin A4P (CA4P) in the treatment of a murine model of retinoblastoma. Results showed that a subconjunctival delivery of CA4P